Følg
Athanassios Vozikis
Athanassios Vozikis
Professor, Laboratory of Health Economics and Management (LabHEM), University of Piraeus
Verificeret mail på unipi.gr - Startside
Titel
Citeret af
Citeret af
År
Patient satisfaction with the healthcare system: Assessing the impact of socio-economic and healthcare provision factors
S Xesfingi, A Vozikis
BMC health services research 16, 1-7, 2016
3212016
Health literacy among university students in Greece: determinants and association with self-perceived health, health behaviours and health risks
A Vozikis, K Drivas, K Milioris
Archives of Public Health 72, 1-6, 2014
1672014
eHealth Literacy: In the Quest of the Contributing Factors
S Xesfingi, A Vozikis
Interactive Journal of Medical Research 5 (2), e16, 2016
1182016
Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece
Y Mai, C Mitropoulou, XE Papadopoulou, A Vozikis, DN Cooper, ...
Personalized Medicine 11 (1), 15-26, 2014
562014
Information management of medical errors in Greece: The MERIS proposal
A Vozikis
International Journal of Information Management 29 (1), 15-26, 2009
552009
MERIS (Medical Error Reporting Information System) as an innovative patient safety intervention: A health policy perspective
M Riga, A Vozikis, Y Pollalis, K Souliotis
Health policy 119 (4), 539-548, 2015
532015
Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke
C Mitropoulou, V Fragoulakis, N Bozina, A Vozikis, S Supe, T Bozina, ...
Pharmacogenomics 16 (2), 137-148, 2015
452015
Test pricing and reimbursement in genomic medicine: towards a general strategy
A Vozikis, DN Cooper, C Mitropoulou, ME Kambouris, A Brand, V Dolzan, ...
Public Health Genomics 19 (6), 352-363, 2017
402017
The recent and projected public health and economic benefits of cigarette taxation in Greece
HR Alpert, CI Vardavas, FJ Chaloupka, A Vozikis, K Athanasakis, ...
Tobacco control 23 (5), 452-454, 2014
392014
Pharmacogenomics and public health: implementing 'populationalized' medicine
L Mette, K Mitropoulos, A Vozikis, GP Patrinos
Pharmacogenomics 13 (7), 803-813, 2012
392012
Economic evaluation in psychiatric pharmacogenomics: a systematic review
K Karamperis, M Koromina, P Papantoniou, M Skokou, F Kanellakis, ...
The pharmacogenomics journal 21 (4), 533-541, 2021
382021
Stakeholder analysis in pharmacogenomics and genomic medicine in Greece
C Mitropoulou, Y Mai, RH Van Schaik, A Vozikis, GP Patrinos
Public Health Genomics 17 (5-6), 280-286, 2014
332014
Prediction of autoimmune diseases by targeted metabolomic assay of urinary organic acids
D Tsoukalas, V Fragoulakis, E Papakonstantinou, M Antonaki, A Vozikis, ...
Metabolites 10 (12), 502, 2020
312020
Application of economic evaluation to assess feasibility for reimbursement of genomic testing as part of personalized medicine interventions
S Simeonidis, S Koutsilieri, A Vozikis, DN Cooper, C Mitropoulou, ...
Frontiers in pharmacology 10, 470729, 2019
292019
Medical decision making for patients with Parkinson disease under Average Cost Criterion
A Vozikis, JE Goulionis
Australia and New Zealand health policy 6 (1), 2009
292009
Impact of cigarette price differences across the entire European Union on cross-border purchase of tobacco products among adults in 2012
I Agaku, E Blecher, O Uyoyo, F Filippidis, A Vozikis, C Vardavas
Tobacco Control, doi:10.1136/tobaccocontrol-2014-052015, 2015
282015
Going up in ashes? Smoking-attributable morbidity, hospital admissions and expenditure in Greece
K Tsalapati, CI Vardavas, K Athanasakis, E Thireos, A Vozikis, E Pavi, ...
The European Journal of Public Health 24 (3), 477-479, 2014
282014
Shadow Economy: Definitions, terms & theoretical considerations
PN Koufopoulou, CC Williams, A Vozikis, K Souliotis
Advances in Management & Applied Economics 9 (5), 35-57, 2019
272019
Bridging genomics research between developed and developing countries: the Genomic Medicine Alliance
DN Cooper, A Brand, V Dolzan, P Fortina, F Innocenti, MT Michael Lee, ...
Personalized medicine 11 (7), 615-623, 2014
272014
Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined …
E Fountzilas, GA Koliou, A Vozikis, V Rapti, A Nikolakopoulos, A Boutis, ...
ESMO open 5 (4), e000774, 2020
262020
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20